Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
about
Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsInflammation and pharmacokinetics: potential implications for HIV-infection.Barriers to HIV remission research in low- and middle-income countries.Primary HIV Infection: Clinical Presentation, Testing, and Treatment.Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients.Evolution of sensory neuropathy after initiation of antiretroviral therapy.Perturbation of B Cell Gene Expression Persists in HIV-Infected Children Despite Effective Antiretroviral Therapy and Predicts H1N1 Response.Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection.Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.Racial Comparison of D-dimer Levels in U.S. Male Military Personnel Before and After HIV Infection and Viral Suppression.Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression.Long-term therapeutic impact of the timing of ART in patients diagnosed with primary HIV-1 infection.The microbiome and HIV persistence: implications for viral remission and cure.Ageing with HIV.Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda
P2860
Q33613493-D27DDA71-54AB-45E5-91CB-7A4A7428030FQ38740792-769CFBD9-E690-4A87-BAC6-E2203CFA7988Q39366791-FB14FA1E-818C-454B-9DDB-33EF3CA6479FQ40051712-B2EBB7FA-4C2E-4935-BF27-5A733EDFF82CQ40098760-83000D44-6854-47E2-B1D6-47D234672DE4Q40179291-5523D9D1-1F4F-4159-AF93-98E690C44777Q41684162-535E63F0-B5C9-4357-992F-FE3B368F8587Q41919143-93B1E93A-879C-43BD-BB33-D75409D9B791Q42367938-E4B18D74-C467-4B36-9A84-C40AC2BE54ADQ46016007-2DE49875-FF77-41D5-AFF9-1F4F151E7F06Q46316709-92E6A797-3D36-4101-B584-2A68F8711FB7Q46668682-AFE7FE11-A4F1-41FC-B1A6-81DD9A757722Q47134781-23B301C9-61F1-4A45-8208-8DC2038BABB9Q47190713-19188EDB-11DA-4343-8016-3F09A5734CA2Q47548478-96668632-EB08-44D9-B15B-950A7D8447A1Q47551904-E21CB2B2-EF61-4A88-A57E-DA05D0C3230BQ47568847-5BC4E8A0-B329-4067-9FA5-C383CF2C674CQ47580980-64E91A12-BCDC-4795-9329-6B83817833A9Q50001938-C7F8D442-41D0-4929-99B6-3D6C54992FACQ51743775-56C6F73B-C431-4C83-9CEE-60B64BC312FFQ53818560-B45E2CD2-1568-4D62-A549-673AA4D1B71EQ55605404-32BFCEA6-E0C4-4D6A-A17B-59A03C7C5D18Q56334211-D3755142-80F6-4C67-9528-A3DCD3B51A5F
P2860
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Persistent, Albeit Reduced, Ch ...... herapy in Acute HIV Infection.
@en
type
label
Persistent, Albeit Reduced, Ch ...... herapy in Acute HIV Infection.
@en
prefLabel
Persistent, Albeit Reduced, Ch ...... herapy in Acute HIV Infection.
@en
P2093
P2860
P50
P356
P1476
Persistent, Albeit Reduced, Ch ...... herapy in Acute HIV Infection.
@en
P2093
Adam Rupert
Bonnie Slike
Daniel C Douek
James L Fletcher
Netanya S Utay
Nittaya Phanuphak
RV254/SEARCH 010, RV304/SEARCH 013 and SEARCH 011 protocol teams
Robert J O'Connell
Shelly J Krebs
Suteeraporn Pinyakorn
P2860
P304
P356
10.1093/CID/CIW683
P407
P577
2016-10-12T00:00:00Z